Identification of class III β-tubulin as a marker of angiogenic perivascular cells

Microvascular Research

Volumn 83, Issue 2, 2012, Pages 257-262

  Stapor, Peter C ^a   Murfee, Walter L ^a  

^a Tulane University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; BIOLOGICAL MARKER; CLASS III BETA TUBULIN; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY LABELING; ARTERIOLE; ARTICLE; CAPILLARY; CELL LABELING; CELL STRUCTURE; CONTROLLED STUDY; DENSITY; IMMUNOHISTOCHEMISTRY; MALE; MESENTERY BLOOD VESSEL; MICROVASCULATURE; NONHUMAN; PERICYTE; PERIVASCULAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; VENULE;

ANIMALS; ANTIGENS; ANTIGENS, CD31; ARTERIOLES; BIOLOGICAL MARKERS; CAPILLARIES; IMMUNOHISTOCHEMISTRY; MALE; MESENTERY; MICROVESSELS; NEOVASCULARIZATION, PHYSIOLOGIC; P-METHOXY-N-METHYLPHENETHYLAMINE; PERICYTES; PHENOTYPE; PROTEOGLYCANS; RATS; RATS, WISTAR; TIME FACTORS; TUBULIN; VENULES;

RATTUS; RATTUS NORVEGICUS;

EID: 84856808779     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2011.09.003     Document Type: Article

References (29)

1. Cicchillitti L., Penci R., Di Michele M., Filippetti F., Rotilio D., Donati M.B., Scambia G., Ferlini C. Proteomic characterization of cytoskeletal and mitochondrial class III beta-tubulin. Mol. Cancer Ther. 2008, 7:2070-2079.
2. Draberova E., Del Valle L., Gordon J., Markova V., Smejkalova B., Bertrand L., de Chadarevian J.P., Agamanolis D.P., Legido A., Khalili K., Draber P., Katsetos C.D. Class III beta-tubulin is constitutively coexpressed with glial fibrillary acidic protein and nestin in midgestational human fetal astrocytes: implications for phenotypic identity. J. Neuropathol. Exp. Neurol. 2008, 67:341-354.
3. Eichmann A., Makinen T., Alitalo K. Neural guidance molecules regulate vascular remodeling and vessel navigation. Genes Dev. 2005, 19:1013-1021.
4. Folkman J., D'Amore P.A. Blood vessel formation: what is its molecular basis?. Cell 1996, 87:1153-1155.
5. Franzen L., Ghassemifar R., Malcherek P. Experimental mast cell activation improves connective tissue repair in the perforated rat mesentery. Agents Actions 1991, 33:371-377.
6. Gan P.P., Pasquier E., Kavallaris M. Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer. Cancer Res. 2007, 67:9356-9363.
7. Gan P.P., McCarroll J.A., Po'uha S.T., Kamath K., Jordan M.A., Kavallaris M. Microtubule dynamics, mitotic arrest, and apoptosis: drug-induced differential effects of betaIII-tubulin. Mol. Cancer Ther. 2010, 9:1339-1348.
8. Gerhardt H., Betsholtz C. Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res. 2003, 314:15-23.
9. Hammes H.P., Lin J., Renner O., Shani M., Lundqvist A., Betsholtz C., Brownlee M., Deutsch U. Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 2002, 51:3107-3112.
10. Hellstrom M., Gerhardt H., Kalen M., Li X., Eriksson U., Wolburg H., Betsholtz C. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J. Cell Biol. 2001, 153:543-553.
11. Hirschi K.K., D'Amore P.A. Pericytes in the microvasculature. Cardiovasc. Res. 1996, 32:687-698.
12. Katsetos C.D., Herman M.M., Mork S.J. Class III beta-tubulin in human development and cancer. Cell Motil. Cytoskeleton 2003, 55:77-96.
13. Katsetos C.D., Legido A., Perentes E., Mork S.J. Class III beta-tubulin isotype: a key cytoskeletal protein at the crossroads of developmental neurobiology and tumor neuropathology. J. Child Neurol. 2003, 18:851-866. discussion 867.
14. Lindahl P., Johansson B.R., Leveen P., Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 1997, 277:242-245.
15. McCarroll J.A., Gan P.P., Liu M., Kavallaris M. betaIII-tubulin is a multifunctional protein involved in drug sensitivity and tumorigenesis in non-small cell lung cancer. Cancer Res. 2010, 70:4995-5003.
16. Murfee W.L., Skalak T.C., Peirce S.M. Differential arterial/venous expression of NG2 proteoglycan in perivascular cells along microvessels: identifying a venule-specific phenotype. Microcirculation 2005, 12:151-160.
17. Murfee W.L., Rehorn M.R., Peirce S.M., Skalak T.C. Perivascular cells along venules upregulate NG2 expression during microvascular remodeling. Microcirculation 2006, 13:261-273.
18. Nehls V., Drenckhahn D. The versatility of microvascular pericytes: from mesenchyme to smooth muscle?. Histochemistry 1993, 99:1-12.
19. Norrby K., Jakobsson A., Sorbo J. Mast-cell-mediated angiogenesis: a novel experimental model using the rat mesentery. Virchows Arch. B. Cell Pathol. Incl Mol. Pathol. 1986, 52:195-206.
20. Ozerdem U. Targeting of pericytes diminishes neovascularization and lymphangiogenesis in prostate cancer. Prostate 2006, 66:294-304.
21. Ozerdem U., Stallcup W.B. Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan. Angiogenesis 2004, 7:269-276.
22. Ozerdem U., Grako K.A., Dahlin-Huppe K., Monosov E., Stallcup W.B. NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis. Dev. Dyn. 2001, 222:218-227.
23. Ozerdem U., Monosov E., Stallcup W.B. NG2 proteoglycan expression by pericytes in pathological microvasculature. Microvasc. Res. 2002, 63:129-134.
24. Peirce S.M., Skalak T.C. Microvascular remodeling: a complex continuum spanning angiogenesis to arteriogenesis. Microcirculation 2003, 10:99-111.
25. Ponce A.M., Price R.J. Angiogenic stimulus determines the positioning of pericytes within capillary sprouts in vivo. Microvasc. Res. 2003, 65:45-48.
26. Sandvig A., Berry M., Barrett L.B., Butt A., Logan A. Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Glia 2004, 46:225-251.
27. Song S., Ewald A.J., Stallcup W., Werb Z., Bergers G. PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat. Cell Biol. 2005, 7:870-879.
28. Tischfield M.A., Baris H.N., Wu C., Rudolph G., Van Maldergem L., He W., Chan W.M., Andrews C., Demer J.L., Robertson R.L., Mackey D.A., Ruddle J.B., Bird T.D., Gottlob I., Pieh C., Traboulsi E.I., Pomeroy S.L., Hunter D.G., Soul J.S., Newlin A., Sabol L.J., Doherty E.J., de Uzcategui C.E., de Uzcategui N., Collins M.L., Sener E.C., Wabbels B., Hellebrand H., Meitinger T., de Berardinis T., Magli A., Schiavi C., Pastore-Trossello M., Koc F., Wong A.M., Levin A.V., Geraghty M.T., Descartes M., Flaherty M., Jamieson R.V., Moller H.U., Meuthen I., Callen D.F., Kerwin J., Lindsay S., Meindl A., Gupta M.L., Pellman D., Engle E.C. Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance. Cell 2010, 140:74-87.
29. Weinstein B.M. Vessels and nerves: marching to the same tune. Cell 2005, 120:299-302.